TITLE

Influencia de las vías de inmunización mucosales sobre la protección contra herpes simple tipo 2 con el AFCo1 como adyuvante

AUTHOR(S)
Cabrera, Osmir; Cuello, Maribel; Thörn, Karolina; Lindqvist, Madelene; Lastre, Miriam; González, Elizabeth; Zayas, Caridad; Balboa, Julio; Romeo, Belkis; Sarandi, Ali M.; Pérez, Oliver
PUB. DATE
September 2011
SOURCE
Revista VacciMonitor (Vacunología y Temas Afines);sep-dic2011, Vol. 20 Issue 3, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mucosal vaccines are a promising strategy to induce mucosal protection. Herpes simplex virus type 2 is the commonest pathogens in the human transmitted by exposure at the genital mucosal surfaces. Many vaccine candidates against this pathogen have been evaluated; but they have not been effective, and neither a prophylactic nor a therapeutic vaccine has been yet obtained. The gD2 is a recombinant glycoprotein and it is reported as one of the antigens of importance for vaccine against this virus. There is the cochleate (AFCol) derived from proteoliposome of Neisseria meningitidis serogroup B. This cochleate has shown potentialities as adjuvant for several immunization routes. The objective of this study was to evaluate the protection induced in mice by the AFCo1-gD2 administered by different mucosal routes. Female mice C57BL/6 were used and immunized by: intranasal (IN), intravaginal (IVag), or intrarectal (IR) routes with AFCo1-gD2 or gD2 alone. The anti-gD2 IgG and specific cellular proliferation were determined and the viral replication in vaginal wash, the signs of disease and the protection against the viral challenge, were measured too. A significant anti-gD2 IgG response was obtained by all routes, although the IN route showed the highest values. Cellular proliferation was observed in cells of animals immunized IN and IVag route; but not by IR route. In addition, a higher protection (100%) in the animals Immunized with AFCol -gD2 by IN route was observed. In conclusion the intranasal is the most promising route in the protection induction against this viral challenge.
ACCESSION #
80135354

 

Related Articles

  • Prediction and Identification of Potential Immunodominant Epitopes in Glycoproteins B, C, E, G, and I of Herpes Simplex Virus Type 2. Mingjie Pan; Xingsheng Wang; Jianmin Liao; Dengke Yin; Suqin Li; Ying Pan; Yao Wang; Guangyan Xie; Shumin Zhang; Yuexi Li // Clinical & Developmental Immunology;2012, p1 

    Twenty B candidate epitopes of glycoproteins B (gB2), C (gC2), E (gE2), G (gG2), and I (gI2) of herpes simplex virus type 2 (HSV-2) were predicted using DNAstar, Biosun, and Antheprot methods combined with the polynomial method. Subsequently, the biological functions of the peptides were tested...

  • Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1. Brans, Richard; Akhrameyeva, Natali V.; Feng Yao // Journal of Investigative Dermatology;Oct2009, Vol. 129 Issue 10, p2470 

    CJ9-gD is a novel herpes simplex virus (HSV) type 1 recombinant virus that is completely replication-defective, expresses high-levels of HSV-1 major antigen glycoprotein D (gD), and can function in trans to inhibit replication of wild-type HSV-1 and HSV-2 in co-infected cells. Here, we show that...

  • Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine. Geltz, Joshua J.; Gershburg, Edward; Halford, William P. // PLoS ONE;Feb2015, Vol. 10 Issue 2, p1 

    Virion glycoproteins such as glycoprotein D (gD) are believed to be the dominant antigens of herpes simplex virus 2 (HSV-2). We have observed that mice immunized with a live HSV-2 ICP0- mutant virus, HSV-2 0ΔNLS, are 10 to 100 times better protected against genital herpes than mice immunized...

  • Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Zhu, Jia; Peng, Tao; Johnston, Christine; Phasouk, Khamsone; Kask, Angela S.; Klock, Alexis; Jin, Lei; Diem, Kurt; Koelle, David M.; Wald, Anna; Robins, Harlan; Corey, Lawrence // Nature;5/23/2013, Vol. 497 Issue 7450, p494 

    Most herpes simplex virus 2 (HSV-2) reactivations in humans are subclinical and associated with rapid expansion and containment of virus. Previous studies have shown that CD8+ T cells persist in genital skin and mucosa at the dermal-epidermal junction (DEJ)-the portal of neuronal release of...

  • Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors. Blanc, Andrea Maria; Berois, Mabel Beatriz; Tomé, Lorena Magalí; Epstein, Alberto L.; Arbiza, Juan Ramón // Journal of Veterinary Science;Mar2012, Vol. 13 Issue 1, p59 

    Herpes simplex virus type-1 (HSV-1) amplicon vectors are versatile and useful tools for transferring genes into cells that are capable of stimulating a specific immune response to their expressed antigens. In this work, two HSV-1-derived amplicon vectors were generated. One of these expressed...

  • IN SILICO EPITOPE PREDICTION FOR GLYCOPROTEIN D IN HUMAN HERPES SIMPLEX VIRUS-1. Yadav, Pramod Kumar; Singh, Raghuvir; Jain, Prashant A.; Singh, Satendra; Gautam, B.; Farmer, R. // International Journal of Pharmaceutical Sciences Review & Resear;Mar/Apr2011, Vol. 7 Issue 2, p148 

    Herpes is an infection that is caused by a herpes simplex virus (HSV). There are two types of herpes simplex virus (HSV) infections. HSV type 1 (HSV-1) more commonly causes cold sores or fever blisters around the mouth. HSV type 2 (HSV-2) more commonly causes genital herpes. Entry of HSV into...

  • HSV (Herpes Simplex Virus).  // Encyclopedic Reference of Molecular Pharmacology;2004, p464 

    A definition of the term "herpes simplex virus" is presented. Herpes simplex viruses (HSV) results in painful rashes on skin and mucous membranes. It mentions some of the symptoms of HSV-1 including sores around the mouth and eyes. HSV-2 results in sores in the genital or anal area. Moreover,...

  • Plasmid DNA--Expressed Secreted and Nonsecreted Forms of Herpes Simplex Virus Glycoprotein D2... Higgins, Terry J.; Herold, Kathleen M.; Arnold, Renee L.; McElhiney, Susan P.; Shroff, Khushroo E.; Pachuk, Catherine J. // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1311 

    Reveals that plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses. Modulation of immune response by expression of varied forms of an antigen; Difference in cellular localization of antigens.

  • High-Level Expression of Glycoprotein D by a Dominant-Negative HSV-1 Virus Augments its Efficacy as a Vaccine against HSV-1 Infection. Lu, Zheming; Brans, Richard; Akhrameyeva, Natali V; Murakami, Nao; Xu, Ximing; Yao, Feng // Journal of Investigative Dermatology;May2009, Vol. 129 Issue 5, p1174 

    Using the T-REx (Invitrogen, Carlsbad, CA) gene switch technology, we previously generated a dominant-negative herpes simplex virus (HSV)-1 recombinant, CJ83193, capable of inhibiting its own replication as well as that of wild-type HSV-1 and HSV-2. It has been further demonstrated that CJ83193...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics